Geneos Wealth Management Inc. Sangamo Therapeutics, Inc Transaction History

Geneos Wealth Management Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Sep 07, 2021	BUY	$8.75 - $13.03 $1,750 - $2,606	200 New	200 $2,000
Q4 2018 Sep 07, 2021	SELL	$9.51 - $16.6 $4,755 - $8,300	-500 Closed	0 $0
Q3 2018 Sep 07, 2021	SELL	$13.05 - $19.05 $13,050 - $19,050	-1,000 Reduced 66.67%	500 $8,000
Q2 2018 Sep 07, 2021	BUY	$13.9 - $19.8 $3,488 - $4,969	251 Added 20.1%	1,500 $21,000
Q1 2018 Sep 07, 2021	SELL	$16.7 - $26.35 $25,384 - $40,052	-1,520 Reduced 54.89%	1,249 $23,000

Q4 2017 Sep 07, 2021	SELL	$11.6 - $17.35 $2,273 - $3,400	-196 Reduced 6.61%	2,769 $45,000
Q3 2017 Sep 07, 2021	BUY	$8.4 - $15.0 $24,906 - $44,475	2,965	2,965 $44,000

138

100M

35.5K

65.8K

Ticker SGMO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 156,552,992
Market Cap $56.4M
Description
Sangamo Therapeutics, Inc., a clinical-stage biotechnology company, focuses on translating science into genomic medicines that transform patients' lives using platform technologies in gene therapy, cell therapy, genome editing, and genome regulation. The company offers zinc finger protein (ZFP), a technology platform for making zinc finger nucle...

Get notified when there are updates to the investment portfolio of Geneos Wealth Management Inc., based on Form 13F filings with the SEC.

Stay updated on Geneos Wealth Management Inc. with notifications on news.